Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections deliver the medication through subcutaneous administration, meaning the needle enters the layer of tissue between skin and muscle. PlexusDx provides compounded semaglutide from licensed 503A pharmacies, with dosing instructions and injection guidance tailored to each patient's treatment plan. Knowing where and how to inject correctly maximizes therapeutic benefit and minimizes discomfort.
Approved Semaglutide Injection Sites on the Body
Semaglutide reaches three primary injection locations: the abdomen, thigh, and upper arm. Each site offers reliable absorption and accessible anatomy for self-injection at home. The abdomen remains the most common choice because the skin is typically looser and easier to pinch, reducing needle-depth variability. Injections into the abdomen should occur 2 inches away from the navel in any direction to avoid sensitive tissue near the belly button.
The thigh provides a second option for patients who prefer rotation or experience abdomen sensitivity. Injections into the outer thigh, on the front or outer surface between hip and knee, allow for easy access without requiring a mirror or awkward positioning. The upper arm, specifically the back of the arm between shoulder and elbow, works well for patients with adequate arm circumference, though self-injection into this site can feel less convenient than abdominal or thigh sites.
Medical research confirms that subcutaneous semaglutide absorption remains consistent across all three approved sites when proper injection depth and technique are followed. Patients may experience slight variations in absorption speed between locations, but these differences typically fall within the therapeutic range and do not require dose adjustment.
How to Rotate Injection Sites and Why It Matters
Site rotation prevents lipodystrophy, a condition where repeated injections into the same small area cause fat tissue to thicken or atrophy. Rotating between abdomen, thigh, and upper arm each week distributes the injection trauma and chemical exposure across larger tissue zones. A practical rotation pattern involves using one body area for four weeks, then switching to a different area for the next four-week cycle.
Within each body area, patients should space individual injections at least one finger-width apart to allow tissue healing between doses. If rotating weekly between sites, inject into a different abdomen region one week, thigh region the next week, and upper arm the following week. This systematic approach prevents inflammation buildup and maintains normal fat tissue appearance underneath the skin.
Lipodystrophy not only affects appearance but can also alter medication absorption rates, potentially reducing the consistency of weight loss and metabolic benefits. Patients on long-term semaglutide therapy who maintain disciplined rotation schedules report fewer injection-site reactions and more stable therapeutic outcomes over months and years of treatment.
Proper Semaglutide Injection Technique and Needle Depth
Subcutaneous injection depth typically ranges from one-quarter to one-half inch into the skin, placing the medication in the fatty tissue layer below the dermis. Most semaglutide injection pens come with 4mm to 6mm needles, which are short enough to minimize pain but long enough to reach subcutaneous tissue reliably. Patients should pinch the skin gently to create a raised fold, then insert the needle at a 45 to 90-degree angle to ensure consistent subcutaneous placement.
After inserting the needle, hold the pen steady for the full injection duration—typically 6 to 10 seconds depending on the dose—to allow complete medication delivery. Pressing the injection button should feel like a gentle click rather than forceful pressure; most modern pens provide tactile and audible feedback when the injection completes. Remove the needle slowly without rubbing the injection site, as friction can increase local inflammation.
Temperature plays a role in injection comfort and medication absorption. Allow the semaglutide pen to sit at room temperature for 30 minutes before injection rather than using a refrigerated pen directly from storage. Cold medication stings more during administration and may slow initial absorption, whereas room-temperature injection feels less painful and enters tissue more smoothly.
PlexusDx Semaglutide: Customized Dosing and Injection Support
PlexusDx compounded semaglutide injection begins at $149 per month across all dose levels, with the pricing structure ensuring that your dose may need to go up, but your price won't. Unlike traditional pharmacy models that charge per-dose amounts, PlexusDx flat pricing removes financial barriers to dose optimization as clinical need increases. Every semaglutide prescription includes detailed injection instructions and access to patient support specialists who can answer questions about technique and site selection.
The PlexusDx Precision Peptide Genetic Test, available as a $99 add-on after the first month of treatment, identifies genetic variants affecting GLP-1 receptor sensitivity (GLP1R rs6923761) and other peptide pathways. Patients with specific genetic profiles may respond more effectively to semaglutide at certain dose ranges, allowing PlexusDx clinicians to personalize not just the medication but the injection schedule and dosing timeline. This genetic insight helps predict how quickly doses may need adjustment, allowing patients to prepare both physically and financially.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into the same spot every week?
No—injecting the same spot repeatedly increases risk of lipodystrophy, which thickens or damages fat tissue and can impair medication absorption. Rotate injection sites systematically across your abdomen, thigh, and upper arm, spacing individual injections at least one finger-width apart within each area. Disciplined rotation maintains normal tissue health and consistent therapeutic response over months of treatment.
Which injection site causes the least pain?
Most patients report less pain from abdominal injections because the skin and fat layer are looser and easier to pinch, reducing needle pressure. The thigh and upper arm can feel more uncomfortable if tissue is tighter or if patients hesitate during needle insertion. Using room-temperature medication and inserting the needle smoothly at a steady angle minimizes discomfort across all sites.
Does semaglutide absorb faster from certain injection locations?
Subcutaneous semaglutide absorption timing is similar across all three approved sites (abdomen, thigh, upper arm) when proper injection depth is maintained. Minor variations in absorption speed between locations fall within acceptable therapeutic ranges and do not require dose changes. Consistent technique matters more than location choice for maintaining stable medication levels.
What is PlexusDx semaglutide pricing and how does it compare to traditional pharmacies?
PlexusDx compounded semaglutide injection starts at $149 per month flat—no per-dose charges, no your dose may need to go up - your price won't adjusts upward. All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible. This flat pricing model ensures patients can optimize their dose for best results without worrying that therapeutic increases will raise their monthly cost.
How does genetic testing help with semaglutide injection planning?
The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants like GLP1R rs6923761 that influence how your body responds to semaglutide. Patients with higher GLP-1 receptor sensitivity may require lower starting doses and slower titration, while others may benefit from faster dose escalation. This genetic insight helps personalize not just your medication, but your injection schedule and cost planning.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic Made for Weight Loss? Understanding Its Purpose and Use
What Percentage of People Gain Weight Back After Mounjaro?